Jurgen Rehm

Summary

Affiliation: University of Zurich
Country: Switzerland

Publications

  1. ncbi Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey
    J Rehm
    Public Health Sciences, University of Applied Sciences, Hamburg, Germany
    Am J Epidemiol 153:64-71. 2001
  2. ncbi Alcohol and cardiovascular disease--more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease--a review
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    J Cardiovasc Risk 10:15-20. 2003
  3. ncbi The role of consumers. Reflection on the possibilities and limits of user interviews in opiate addiction treatment
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Subst Use Misuse 37:533-6. 2002
  4. ncbi Global monitoring of average volume of alcohol consumption
    Jurgen Rehm
    Addiction Research Institute, Zurich
    Soz Praventivmed 47:48-58. 2002
  5. ncbi [From "Burden of disease" research to the conception of an integrated care system for substance abuse in Ontario]
    J Rehm
    Institut für Suchtforschung, Zürich Schweiz, Switzerland
    Psychiatr Prax 28:S68-72. 2001
  6. ncbi Average volume of alcohol consumption, drinking patterns and related burden of mortality in young people in established market economies of Europe
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 7:148-51. 2001
  7. ncbi Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 7:138-47. 2001
  8. ncbi Mortality in heroin-assisted treatment in Switzerland 1994-2000
    Jurgen Rehm
    Addiction Research Institute, Konradstr 32, CH 8031 Zurich, Switzerland
    Drug Alcohol Depend 79:137-43. 2005
  9. ncbi Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study
    Patrick Gschwend
    Addiction Research Institute, University of Zurich, Zurich, Switzerland
    Eur Addict Res 10:41-8. 2004
  10. ncbi Alcohol as a risk factor for global burden of disease
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 9:157-64. 2003

Collaborators

Detail Information

Publications25

  1. ncbi Average volume of alcohol consumption, patterns of drinking, and all-cause mortality: results from the US National Alcohol Survey
    J Rehm
    Public Health Sciences, University of Applied Sciences, Hamburg, Germany
    Am J Epidemiol 153:64-71. 2001
    ..Finally, indicating alcohol problems in the past was related to higher mortality risk. Results emphasized the importance of routinely including measures of drinking patterns into future epidemiologic studies on alcohol-related mortality...
  2. ncbi Alcohol and cardiovascular disease--more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease--a review
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    J Cardiovasc Risk 10:15-20. 2003
    ..Since patterns of drinking are important in determining CHD risk, they should be included in future epidemiologic studies, together with biomarkers further to test hypotheses about pathways...
  3. ncbi The role of consumers. Reflection on the possibilities and limits of user interviews in opiate addiction treatment
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Subst Use Misuse 37:533-6. 2002
  4. ncbi Global monitoring of average volume of alcohol consumption
    Jurgen Rehm
    Addiction Research Institute, Zurich
    Soz Praventivmed 47:48-58. 2002
    ..To check how the monitored indicator of average volume relates to prevalence of alcohol dependence. To discuss conclusions for establishing a global monitoring system...
  5. ncbi [From "Burden of disease" research to the conception of an integrated care system for substance abuse in Ontario]
    J Rehm
    Institut für Suchtforschung, Zürich Schweiz, Switzerland
    Psychiatr Prax 28:S68-72. 2001
    ..The paper discusses difficulties in implementing the system and gives some indications on future developments...
  6. ncbi Average volume of alcohol consumption, drinking patterns and related burden of mortality in young people in established market economies of Europe
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 7:148-51. 2001
    ..Two dimensions of alcohol consumption were considered: average volume of consumption, and patterns of drinking...
  7. ncbi Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences
    J Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 7:138-47. 2001
    ..In addition, using methodology based on aggregate data, patterns were relevant for attributing harms for men but not women...
  8. ncbi Mortality in heroin-assisted treatment in Switzerland 1994-2000
    Jurgen Rehm
    Addiction Research Institute, Konradstr 32, CH 8031 Zurich, Switzerland
    Drug Alcohol Depend 79:137-43. 2005
    ..A major goal of heroin-assisted treatment in Switzerland has been to reduce the drug-related mortality of heroin users. Therefore, a continuous monitoring of deaths under treatment is essential...
  9. ncbi Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study
    Patrick Gschwend
    Addiction Research Institute, University of Zurich, Zurich, Switzerland
    Eur Addict Res 10:41-8. 2004
    ..This contribution analyses the course of dose levels during the treatment period...
  10. ncbi Alcohol as a risk factor for global burden of disease
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 9:157-64. 2003
    ..To make quantitative estimates of the burden of disease attributable to alcohol in the year 2000 on a global basis...
  11. ncbi Alcohol-related morbidity and mortality
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Alcohol Res Health 27:39-51. 2003
    ..Broad summary measures that reflect alcohol's possible effects on morbidity, mortality, and disability may be more useful than measures of any one outcome alone...
  12. ncbi Does price matter? The effect of decreased price on spirits consumption in Switzerland
    Meichun Kuo
    Addiction Research Institute, Zurich University, Switzerland
    Alcohol Clin Exp Res 27:720-5. 2003
    ....
  13. ncbi Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002
    Miriam Gerlich
    Research Institute for Public Health and Addiction, Konradstrasse 32, CH 8031, Zurich, Switzerland
    Eur J Epidemiol 21:545-9. 2006
    ..Hepatitis C virus (HCV) remains very prevalent in injection drug users (IDUs). In spite of recommended vaccinations against hepatitis A virus (HAV) and hepatitis B virus (HBV), many IDUs remain susceptible to HAV and HBV...
  14. ncbi A prospective cohort study on orally administered heroin substitution for severely addicted opioid users
    Ulrich Frick
    Research Institute for Addiction and Public Health, Zurich, Switzerland
    Addiction 101:1631-9. 2006
    ..To assess the efficacy and safety of orally administered heroin [diacetylmorphine (DAM)] tablets in substitution treatment of severely addicted opioid users...
  15. ncbi Long-term follow-up of orally administered diacetylmorphine substitution treatment
    Ulrich Frick
    Research Institute for Public Health and Addiction, Zurich, Switzerland
    Eur Addict Res 16:131-8. 2010
    ..To assess the long-term course of the feasibility and safety of orally administered heroin [diacetylmorphine (DAM)] tablets in substitution treatment of severely addicted opioid users...
  16. ncbi Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up
    Franziska Güttinger
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 9:73-9. 2003
    ..Heroin-assisted treatment is thus efficacious in the long-term course of treatment and is still effective after termination of treatment with respect to living conditions and use of illicit substances...
  17. ncbi Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002
    Jurgen Rehm
    Institut für Sucht und Gesundheitsforschung ISGF Research Institute for Public Health and Addictions, Zurich, Switzerland
    Addiction 101:1086-95. 2006
    ..To describe the volume of alcohol consumption and patterns of drinking in the World Health Organization (WHO) European regions in 2002 and to estimate quantitatively the burden of disease attributable to alcohol in that year...
  18. ncbi Alcohol use disorders in EU countries and Norway: an overview of the epidemiology
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Neuropsychopharmacol 15:377-88. 2005
    ..rural and AUD prevalence. The discussion highlights potential explanations for the high variability of prevalence between countries, and the fact, that AUD constitute only a small part of all alcohol-related harm...
  19. ncbi The global distribution of average volume of alcohol consumption and patterns of drinking
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 9:147-56. 2003
    ..To make quantitative estimates on a global basis of exposure of disease-relevant dimensions of alcohol consumption, i.e. average volume of alcohol consumption and patterns of drinking...
  20. ncbi Development of a monitoring system for heroin-assisted substitution treatment in Switzerland
    Patrick Gschwend
    Addiction Research Institute, Zurich
    Soz Praventivmed 47:33-8. 2002
    ..As a result the evaluation instruments were changed from a detailed scientific project to a routine monitoring system. The process for developing this monitoring system is described...
  21. ncbi Comparison perception of singular transcranial magnetic stimuli by subjectively electrosensitive subjects and general population controls
    Ulrich Frick
    Psychiatric University Hospital, Regensburg, Germany
    Bioelectromagnetics 26:287-98. 2005
    ..Further research should focus on disposing factors explaining the unspecific sensory hyperresponsiveness of subjectively electrosensitive subjects...
  22. ncbi Decreased taxation, spirits consumption and alcohol-related problems in Switzerland
    Meichun Mohler-Kuo
    Addiction Research Institute ISF, Konradstrasse 32, Postfach 8031 Zürich, Switzerland
    J Stud Alcohol 65:266-73. 2004
    ..Further correlates of alcohol-related problems were also explored...
  23. ncbi Alcohol consumption and alcohol-attributable burden of disease in Switzerland, 2002
    Jurgen Rehm
    ISGF Research Institute for Public Health and Addiction, Zurich
    Int J Public Health 52:383-92. 2007
    ..This analysis estimated alcohol-attributable burden of disease for Switzerland...
  24. ncbi The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview
    Jurgen Rehm
    Addiction Research Institute, Zurich, Switzerland
    Addiction 98:1209-28. 2003
    ..AAFs were estimated as a function of prevalence of exposure and relative risk, or from combining the aggregate multi-level analyses with prevalence data...
  25. ncbi Modes and impact of coercive inpatient treatment for drug-related conditions in Switzerland
    Esther Grichting
    Addiction Research Institute, Zurich, Switzerland
    Eur Addict Res 8:78-83. 2002
    ..Two forms of institutionalized pressure to treatment can be distinguished in Switzerland: civil commitment and court referral. In court referral, the referred patient has the right to refuse treatment...